Helixgate https://validator.w3.org/feed/docs/rss2.html Home StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO Neumora discards depression asset, lays off staffers after pair of late-stage flops Germany rethinking drug price reforms after Lilly, Boehringer withdraw investments: Reuters AI Predicts Gene Regulation for Drug Discovery Using Condensate Morphology Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3 STAT+: Lilly’s Ajax acquisition may have been worth it STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more STAT+: Where ‘democracy met science,’ 50 years ago Rhythm’s obesity drug scores ‘better than expected’ weight loss in rare genetic disease Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy Celiac disease is entering a new era of therapeutic innovation The commercial launch playbook: Team structure, readiness and execution Despite FDA trial clearance, ibogaine metabolite won’t receive red carpet treatment Consummate chameleon Amylyx nears regulatory run in obesity surgery complication How does ibogaine work? Understanding matrix logic to make a safer drug Collagen Resides Inside Cells in Liquid Condensate-Like Form Sanofi wins type 1 diabetes nod for Tzield after requesting to revoke CNPV STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes An obesity drug deep-dive, and peptides move mainstream STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end Nonprofit buys experimental cancer drug to maintain patient access Potential Cocaine Addiction Targets Identified Through Genetic Mapping in Rats Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73 STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model FDA imposes import alert on Indian plant after inspectors flag GMP failings FDA imposes import alert on Indian plant after inspectors flag GMP failings Rapport ‘fully prepared’ to launch seizure drug solo, CEO says STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more Amgen shores up Tavneos’ FDA defense with Duke data analysis RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year This week in Drug Discovery (8 June – 12 June)  Chile offers new data on food warning label efficacy Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win ‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins Rewiring oncogenic signalling to precision ablation of metastatic cancer STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America New mRNA Delivery Platform Restores Muscle Function in DMD Models STAT+: Abridge inks deals with Nvidia and Lilly Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’ Summit pulls $500M share sale a day after announcing it Fighting Antimicrobial Resistance with Biomaterials and Phages SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years STAT+: Up and down the ladder: The latest comings and goings